P3 Health Partners Inc.
PIII
$2.64
$0.020.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.96% | -4.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.96% | -4.67% | |||
| Cost of Revenue | 5.25% | -5.56% | |||
| Gross Profit | -652.86% | 275.47% | |||
| SG&A Expenses | -4.50% | -6.89% | |||
| Depreciation & Amortization | -0.24% | 0.15% | |||
| Other Operating Expenses | -297.79% | 14.29% | |||
| Total Operating Expenses | -0.11% | -5.20% | |||
| Operating Income | -29.60% | 10.41% | |||
| Income Before Tax | -66.61% | 3.45% | |||
| Income Tax Expenses | -99.44% | 84.62% | |||
| Earnings from Continuing Operations | -59.08% | 1.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 62.53% | -1.95% | |||
| Net Income | -55.13% | 0.58% | |||
| EBIT | -29.60% | 10.41% | |||
| EBITDA | -77.82% | 23.45% | |||
| EPS Basic | -55.08% | 0.79% | |||
| Normalized Basic EPS | -101.15% | 14.71% | |||
| EPS Diluted | -55.15% | 0.79% | |||
| Normalized Diluted EPS | -101.15% | 14.71% | |||
| Average Basic Shares Outstanding | 0.03% | 0.21% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||